[1] Banin Hirata BK, Oda JM, Losi Guembarovski R, et al. Molecular markers for breast cancer: prediction on tumor behavior[J]. Dis Markers, 2014, 2014: 1-12.
[2] 曹银芳, 丁海涛. 乳腺癌相关标志物的研究进展[J]. 内蒙古医科大学学报, 2017, 39(5):477-480.
[3] 魏晶, 陈纪飞, 王冰, 等. TMEM 家族成员免疫功能的研究进展[J]. 中国免疫学杂志, 2016, 32(1): 127-130.
[4] Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal[J]. Sci Signal, 2013, 6(269): pl1.
[5] Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses[J]. Neoplasia, 2017, 19(8): 649-658.
[6] Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types[J]. Nucleic Acids Res, 2018, 46(D1): D956-D963.
[7] Roy C, Choudhury KB, Saha A, et al. Metaplastic carcinoma of the breast: A case report with review of literature[J]. Indian J Cancer, 2014, 51(3): 381-383.
[8] Tao Z, Shi A, Lu C, et al. Breast cancer: epidemiology and etiology[J]. Cell Biochem Biophys, 2015, 72(2): 333-338.
[9] 韩璐, 宋丰举, 陈可欣. 乳腺癌预后生物标志物研究进展[J]. 天津医药. 2016, 44(4): 404- 407.
[10]Dodeller F, Gottar M, Huesken D, et al. The lysosomal Transmembrane protein 9B regulates the activity of inflammatory Signaling pathways[J]. J Biol Chem, 2008, 283(31): 21487-21494.
[11]Yu C, Wang L, Lv B, et al. TMEM74, a lysosome and autophagosome protein, regulates autophagy[J]. Biochem Biophys Res Commun, 2008, 369(2): 622-629.
[12]Conda mine T, Le Texier L, Howie D, et al. Tmem176B and Tmem176A are associated with the immature state of dendritic cells[J]. J Leukoc Biol, 2010, 88(3): 507-515.
[13]Wang H, Zou L, Ma K, et al. Cell-specific mechanisms of TMEM16A Ca(2+)-activated chloride channel in cancer[J]. Mol Cancer, 2017, 16(1): 152.
[14]Liu F, Cao QH, Lu DJ, et al. TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-beta signaling[J]. Oncotarget, 2015, 6(13): 11585-11599.
[15]Wu H, Guan S, Sun M, et al. Ano1/TMEM16A Overexpression Is Associated with Good Prognosis in PR-Positive or HER2-Negative Breast Cancer Patients following Tamoxifen Treatment[J]. PloS One, 2015, 10(5): e0126128.
[16]Cuajungco MP, Podevin W, Valluri VK, et al. Abnormal accumulation of human transmembrane (TMEM)-176A and 176B proteins is associated with cancer pathology[J]. Acta Histochem, 2012, 114(7): 705-712.
[17]Guestini F, McNamara KM, Ishida T, et al. Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification[J]. Expert Opin Ther Targets, 2016, 20 (6): 705-720.
[18]夏一芳, 潘继红, 常晓天. DNA拷贝数变化与肿瘤[J]. 国际肿瘤学杂志, 2012, 39(8): 563-566.
[19]Gokul G, Khosla S. DNA methylation and cancer[J]. Subcell Biochem, 2013, 61: 597-625.
[20]Yang X, Han H, De Carvalho DD, et al. Gene body methylation can alter gene expression and is a therapeutic target in cancer[J]. Cancer Cell, 2014, 26(4): 577-590. |